Latest news
Moderna Says Its Norovirus Vaccine Missed an Early Success Threshold, and the Trial Will Continue - medicaldaily.commedicaldaily.com · Wed, 05 Aug 2026 11:00:46 GMTNo early success for Moderna’s norovirus vaccine in phase 3 trial - CIDRAPCIDRAP · Mon, 03 Aug 2026 18:09:00 GMTModerna Narrows 2Q Loss, Says New Norovirus Vaccine Didn't Meet Expectations in Late-Stage Trial - MoomooMoomoo · Fri, 31 Jul 2026 11:30:00 GMTModerna Says Norovirus Vaccine Didn’t Meet Statistical Criteria for Early Success in Trial - WSJWSJ · Fri, 31 Jul 2026 07:00:00 GMTModerna maintains 10% growth target despite Phase 3 norovirus miss - BioSpaceBioSpace · Fri, 31 Jul 2026 07:00:00 GMTModerna's Q2 revenue beat tempered by norovirus vaccine setback - FirstWord PharmaFirstWord Pharma · Fri, 31 Jul 2026 07:00:00 GMTModerna Norovirus Vaccine Fails Interim Bar: Trial Extends Into Fourth Season - Tech TimesTech Times · Fri, 31 Jul 2026 07:00:00 GMTMRNA Q2 Earnings Meet, Stock Down on Norovirus Vaccine Setback - Yahoo FinanceYahoo Finance · Fri, 31 Jul 2026 07:00:00 GMT